The treatment of many patients with peripheral artery disease is not optimal, and indeed is much worse than that in patients ...

Among patients with diabetes and peripheral artery disease, semaglutide 1 mg increased walking distance vs. placebo, ...

Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building its ...

Keywords Diabetes Mellitus, Retinopathy, Neuropathy, Nephropathy, Cardiovascular Disease Share and Cite: Mohammed, S. , ...

Lucia Notterpek, Ph.D., professor and senior associate dean for research at the University of Nevada, Reno School of Medicine ...

Painful diabetic neuropathy was associated with lower quality of life and higher rates of depression and anxiety than painless diabetic neuropathy.

The nervous system is a complex network of neurons ... in particular are a mostly fatal disease group with a median survival time of less than 18 months after diagnosis and limited treatment ...

Nadunolimab's additional potential in mitigating neuropathy demonstrated by data from Cantargia's CESTAFOUR and CAPAFOUR clinical studiesPotential neuroprotective effect ...

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

and compression of the peripheral nerves that travel to the hands and feet can cause conditions like carpal tunnel syndrome (compression of the median nerve, affecting the hand and wrist) and tarsal ...

Data on sex differences in peripheral vascular disease are ill defined, and there is a need to report and understand those sex-related differences to mitigate adverse outcomes related to those ...